Research

Findings identify a novel pharmacological target for drug development Researchers at McGill University have found that sodium – the main chemical component in...

Reducing levels of nerve-growth factor may be a key to developing better pain treatments Arthritis is a debilitating disorder affecting one in 10...

Victims of childhood maltreatment or sexual abuse often suffer from serious psychiatric disorders as well as sexual dysfunction. The underlying mechanisms mediating this...

Children on dialysis for severe kidney disease have a dramatically reduced risk of death compared to 20 years ago, a new study shows....

Researchers at the Douglas Mental Health University Institute, have discovered a new genetic process that could one day provide a novel target for...

A multi-disciplinary team led by the Research Institute of the McGill University Health Centre (RI MUHC), in collaboration with the Lady Davis Institute...

Vitamin B12 is essential to human health. However, some people have inherited conditions that leave them unable to process vitamin B12. As a...

Caffeine, which is widely consumed around the world in coffee, tea and soft drinks, may help control movement in people suffering from Parkinson's....

Researchers at McGill University Health Center (MUHC) and the Jewish General Hospital found that patients exposed to low-dose ionizing radiation from cardiac imaging...

The collaboration, backed by $200,000 in annual funding for three years, will see the institutions exchange scientists, develop research projects, establish fellowships for...

New research led by McGill Biochemist Dr. William Muller helps explain why breast-milk cells lose their structure, causing them to clump up in...

Chagas disease affects more than 10 million people, primarily in the Americas. In South America alone it kills 50 000 people each year....